Antonio Ucar

Thrombotic microangiopathy and retroviral infections: A 13‐year experience

Antonio Ucar, Hugo F. Fernández, John Byrnes et al. · American Journal of Hematology · 1994 · 68 citations

Nivolumab (NIVO) + 5-fluorouracil/leucovorin/oxaliplatin (mFOLFOX6)/bevacizumab (BEV) versus mFOLFOX6/BEV for first-line (1L) treatment of metastatic colorectal cancer (mCRC): Phase 2 results from CheckMate 9X8.

Heinz‐Josef Lenz, Aparna R. Parikh, David R. Spigel et al. · Journal of Clinical Oncology · 2022 · 58 citations

Health Sciences, Medicine, Standard Therapies +15

Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trial

Heinz‐Josef Lenz, Aparna R. Parikh, David R. Spigel et al. · Journal for ImmunoTherapy of Cancer · 2024 · 57 citations · Full text

A Randomized, Phase II Trial of Cetuximab With or Without PX-866, an Irreversible Oral Phosphatidylinositol 3-Kinase Inhibitor, in Patients With Metastatic Colorectal Carcinoma

Daniel W. Bowles, Mark D. Kochenderfer, Allen Lee Cohn et al. · Clinical Colorectal Cancer · 2016 · 42 citations

Oncology, Phase Ii Trial, Medicine +6

Induction Chemotherapy and Ablative Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy for Inoperable Pancreas Cancer

Michael D. Chuong, Roberto Herrera‐Goepfert, Adeel Kaiser et al. · Frontiers in Oncology · 2022 · 41 citations · Full text